Variable | B | SE | Wald | P | Hazard ratio | 95% CI |
---|---|---|---|---|---|---|
Group | ||||||
Monotherapy | – | – | – | – | – | – |
Combination therapy | 0.93 (0.92) | 0.48 (0.48) | 1.94 (1.90) | 0.052 (0.058) | 2.56 (2.51) | 0.99–6.61 (0.97–6.50) |
Side effect severity | 0.02 (0.02) | 0.08 (0.09) | 0.27 (0.27) | 0.785 (0.785) | 1.02 (1.02) | 0.87–1.21 (0.86–1.21) |
Side effect severity × group | 0.01 (0.00) | 0.09 (0.09) | − 0.43 (0.01) | 0.939 (0.992) | 1.01 (1.00) | 0.85–1.20 (0.84–1.19) |
YMRS | 0.00 (− 0.00) | 0.03 (0.03) | 0.04 (− 0.03) | 0.965 (0.973) | 1.00 (1.00) | 0.95–1.06 (0.95–1.05) |
HAM-D | 0.06 (0.07) | 0.03 (0.03) | 1.74 (2.06) | 0.082 (0.039*) | 1.06 (1.07) | 0.99–1.14 (1.00–1.14) |
Site | − 1.02 | 1.05 | − 0.97 | 0.334 | 0.36 | 0.05–2.85 |